参考文献/References:
[1]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[2]Heather Wakelee.50 Years of Progress in the Systemic Therapy of Non-Small Cell Lung Cancer[J].Am Soc Clin Oncol Educ Book,2014:177-89.
[3]Hirsch FR,Scagliotti GV,Mulshine JL,et al.Lung cancer:current therapies and new targeted treatments[J].Lancet,2017,389(10066):299-311.
[4]吴军,杨小平.分子靶向药物治疗非小细胞肺癌的研究进展[J].医学理论与实践,2019, 32(10):1489-1490.
[5]Ren PT,Zhang Y.Comparative investigation of the effects of specific antigen?sensitized DC-CIK and DC-CTL cells against B16 melanoma tumor cells[J].Mol Med Rep,2017,15(4):1533-1538.
[6]人体细胞治疗研究和制剂质量控制技术指导原则(国家食药监督局文件), http://samr.cfda.gov.cn/WS01/CL0237/15709.html
[7]Gao D,Li C,Xie X,et al.Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients[J].PLoS One,2014,9(4):e93886.
[8]韦庄怡,任小朋,王博.DC-CIK自体回输对化疗后胃癌患者T淋巴细胞亚群及NK细胞的影响[J].临床和实验医学杂志,2019,18(11):1179-1182.
[9]单海霞,黄广清.DC-CIK联合化疗治疗进展期胃癌45例的临床疗效评价[J].胃肠病学和肝病学杂志,2014,23(12):1416-1419.
[10]王金烁,谢泽新,李慧杰.DC-CIK联合化疗治疗晚期胃癌的近期疗效[J].实用肿瘤杂志,2016,31(1):38-42.
[11]吴有军,曹志宇,张庆军.DC-CIK对结直肠癌根治术后肝转移患者疗效和循环肿瘤细胞的影响[J].中国肿瘤生物治疗杂志,2018,25(1):89-93.
[12]Mai HX,Mei GH,Zhao FL,et al.Retrospective analysis on the efficacy of sunitinib/sorafenib in combination with dendritic cells-cytokine-induced killer in metastasis renal cell carcinoma after radical nephrectomy[J].Cancer Res Ther,2018,14(Supplement):S427-S432.
[13]Qin W,Xiong Y,Chen J,et al.DC-CIK cells derived from ovarian cancer patient menstrual blood activate the TNFR1-ASK1-AIP1 pathway to kill autologous ovarian cancer stem cells[J].Cell Mol Med,2018,22(7):3364-3376.
[14]Hu J,Hu J,Liu X,et al.Effect and safety of cytokine-induced killer (CIK) cell immunotherapy in patients with breast cancer[J]. Medicine,2017,96(42):e8310.
[15]Xiao X,Ye X,Xu C,et al.Successful alternative treatment for relapsed adult acute lymphoblastic leukemia with dendritic cells-cytokine-induced killer cells combined with a rituximab-based regimen[J].Onco Targets Ther,2018,29(11):7555-7558.
[16]Dhupkar P,Gordon N.Interleukin-2:Old and New Approaches to Enhance Immune-Therapeutic Efficacy[J].Adv Exp Med Biol,2017(995):33-51.
[17]Gong W,Hoffmann JM,Stock S,et al.Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells[J].Cancer Immunol Immunother,2019,68(7):1195-1209.
[18]Wang L,Wang Y,Song Z,et al.Interferon Cytokine Res[J]. Deficiency of interferon-gamma or its receptor promotes colorectal cancer development,2015,35(4):273-280.
相似文献/References:
[1]尤 静.肺癌患者外周血CEA、NSE、CYFRA21-1联合检测的意义[J].医学信息,2018,31(06):149.[doi:10.3969/j.issn.1006-1959.2018.06.052]
YOU Jing.Clinical Significance of Combined Detection of CEA,NSE,CYFRA21-1 in Peripheral Blood of Patients with Lung Cancer[J].Journal of Medical Information,2018,31(20):149.[doi:10.3969/j.issn.1006-1959.2018.06.052]
[2]戴 芳,曹晓美,王莉娜.肺癌患者疾病不确定感的影响因素与干预措施研究现状[J].医学信息,2018,31(08):35.[doi:10.3969/j.issn.1006-1959.2018.08.012]
DAI Fang,CAO Xiao-mei,WANG Li-na.Research Status on Influencing Factors and Intervention Measures of Disease Uncertainty in Patients with Lung Cancer[J].Journal of Medical Information,2018,31(20):35.[doi:10.3969/j.issn.1006-1959.2018.08.012]
[3]吴 倩,王一非.中西医结合治疗肺癌脑转移疗效与安全性的Meta分析[J].医学信息,2022,35(10):120.[doi:10.3969/j.issn.1006-1959.2022.10.029]
WU Qian,WANG Yi-fei.Meta-analysis of Efficacy and Safety of Integrated Traditional Chinese and Western Medicine in the Treatment of Brain Metastasis of Lung Cancer[J].Journal of Medical Information,2022,35(20):120.[doi:10.3969/j.issn.1006-1959.2022.10.029]
[4]王晓军.以时间护理为基础的呼吸训练与排痰管理对肺癌手术患者康复的影响研究[J].医学信息,2022,35(11):180.[doi:10.3969/j.issn.1006-1959.2022.11.048]
WANG Xiao-jun.Effect of Respiratory Training and Expectoration Management Based on Time Nursing on Rehabilitation of Patients with Lung Cancer Surgery[J].Journal of Medical Information,2022,35(20):180.[doi:10.3969/j.issn.1006-1959.2022.11.048]
[5]邢益辉,刘 曼,厉玛倩倩,等.快速康复对肺癌手术患者并发症发生及生活质量的影响研究[J].医学信息,2018,31(16):168.[doi:10.3969/j.issn.1006-1959.2018.16.054]
XING Yi-hui,LIU Man,LIMA Qian-qian,et al.Effect of Rapid Rehabilitation on Complications and Quality of Life in Patients with Lung Cancer Surgery[J].Journal of Medical Information,2018,31(20):168.[doi:10.3969/j.issn.1006-1959.2018.16.054]
[6]朱晓晓,张 顺,蔡 挺.镍暴露相关的肺癌发生分子机制研究[J].医学信息,2018,31(17):4.[doi:10.3969/j.issn.1006-1959.2018.17.002]
ZHU Xiao-xiao,ZHANG Shun,CAI Ting.Molecular Mechanism of Lung Cancer Related to Nickel Exposure[J].Journal of Medical Information,2018,31(20):4.[doi:10.3969/j.issn.1006-1959.2018.17.002]
[7]付云杰.肺癌患者血浆D-二聚体、NSE及CYFRA21-1联合检测的临床价值[J].医学信息,2018,31(23):161.[doi:10.3969/j.issn.1006-1959.2018.23.047]
FU Yun-jie.Clinical Value of the Plasma D-dimer and Serum NSE,CYFRA21-1 Combined Detection in the Diagnosis of Lung Cancer[J].Journal of Medical Information,2018,31(20):161.[doi:10.3969/j.issn.1006-1959.2018.23.047]
[8]覃柳麻,何慧敏.2014~2016年广西肿瘤医院肺癌患者流行病学及病理分布特征分析[J].医学信息,2019,32(05):67.[doi:10.3969/j.issn.1006-1959.2019.05.021]
QIN Liu-ma,HE Hui-min.Epidemiological and Pathological Distribution Characteristics of Lung Cancer Patients in Guangxi Cancer Hospital from 2014 to 2016[J].Journal of Medical Information,2019,32(20):67.[doi:10.3969/j.issn.1006-1959.2019.05.021]
[9]魏优蕾,郭晓彤.肺癌患者血浆检测肿瘤标志物的分析方法及展望[J].医学信息,2019,32(07):39.[doi:10.3969/j.issn.1006-1959.2019.07.014]
WEI You-lei,GUO Xiao-Tong.Analytical Methods and Prospects of Plasma Detection of Tumor Markers in Patients with Lung Cancer[J].Journal of Medical Information,2019,32(20):39.[doi:10.3969/j.issn.1006-1959.2019.07.014]
[10]杨寿林,宋庆志,吴路发,等.肿瘤标志物和凝血指标在肺癌辅助诊断中的效果分析[J].医学信息,2019,32(07):168.[doi:10.3969/j.issn.1006-1959.2019.07.053]
YANG Shou-lin,SONG Qing-zhi,WU Lu-fa,et al.Efficacy Analysis of Tumor Markers and Coagulation Parameters in the Diagnosis of Lung Cancer[J].Journal of Medical Information,2019,32(20):168.[doi:10.3969/j.issn.1006-1959.2019.07.053]